Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site study.
In the near future, patients won’t have to waste time and be disappointed with months of ineffective therapy, scientists said.
“Now we can start to predict which drugs a patient will respond to,” said co-senior author Harris Perlman, chief of rheumatology at Northwestern University Feinberg School of Medicine. “We can truly do precision medicine for rheumatoid arthritis. I believe this could be game changing. ”
The paper was recently published as an uncorrected proof in Arthritis & Rheumatology and will be officially published in the journal in late May. Richard Pope and Deborah Winter also are lead Northwestern authors.
Treatment for rheumatoid arthritis now is trial and error.
“We have so many different biologic drugs and there’s no rhyme or reason to give one drug versus the other,” Perlman said. “We waste $2.5 billion a year in ineffective therapy. And patients go through 12 weeks of therapy, don’t respond and get upset.”
Scientists in the multi-site study were the first in the U.S. to use ultrasound-guided therapy to take a tissue biopsy in the affected joint. In the past, blood samples were used to try to determine the effectiveness of the therapy and disease progression.
“It’s just like oncology, where you go to the tumor,” Perlman said. “Why go anywhere else? In rheumatoid arthritis, we’ve never gone to the target organ.”
Improved ultrasound guided techniques make the new technique possible, Perlman said, noting joint biopsies began in Europe about six years ago.
Scientists in the six-site study analyzed the tissue in 41 rheumatoid arthritis patients, separating out different immune cell populations. They focused on macrophages, essentially the garbage collectors of the immune system that are overactive in rheumatoid arthritis. These cells produce toxic, inflammatory proteins that destroy the joints. Biologic therapy removes the protein molecules being secreted by the macrophages.
The study included 30 patients from Northwestern and the remaining 11 from the University of Alabama at Birmingham; Washington University, Columbia University, Mayo Clinic and University of Michigan.
In the past, scientists have tried to determine therapeutic effectiveness by separating patients into groups based on their clinical parameters such as what antibodies they are producing against themselves, how swollen their joints are and medications they are taking. Then scientists tried to see if these parameters could predict therapeutic efficacy. But that hasn’t worked, Perlman said.
Instead, Perlman and colleagues segregated patients based on the genes being produced by their macrophages. They identified two patient groups who shared aspects of the genetic profiles.
Next, the scientists identified which of these patient populations had joints that were getting better and what biologic therapies they were taking. They also identified a gene sequence associated in patients with early disease. The earlier the patient is treated, the more effective the therapy.
The next goal is to predict which patients will have the best response — based on their genetic signature — to a specific drug.
In a new study, researchers are taking joint biopsy tissue from patients at the start of a new therapy and then six weeks later to see if they can find a predictor gene sequence that will clearly identify which patients respond to a particular therapy.
“The idea is to develop gene sequences to predict whether a patient will respond or not,” Perlman said. “Our goal is that this procedure will become the standard of care of for all patients with rheumatoid arthritis.”
Learn more: Rheumatoid arthritis meets precision medicine
The Latest on: Rheumatoid arthritis
via Google News
The Latest on: Rheumatoid arthritis
- Synovial signatures signpost arthritis on April 17, 2019 at 11:59 am
Cellular signatures define pathobiological endotypes in early rheumatoid arthritis, informing prognosis and treatment. Advances in understanding the pathogenesis of rheumatoid arthritis (RA) have ... […]
- Non-invasive vagus nerve stimulation shows promise for treatment of rheumatoid arthritis on April 17, 2019 at 12:48 am
Bioelectronic medicine scientists at The Feinstein Institute for Medical Research collaborated with counterparts from Academic Medical Center at University of Amsterdam in the Netherlands to carry ... […]
- New Study Suggests Cannabis May Be Used to Treat Rheumatoid Arthritis on April 16, 2019 at 4:21 am
Cannabis may be an effective treatment for rheumatoid arthritis, according to a new study published in the journal Current Opinion in Rheumatology. Researchers, who noted that “an increasing ... […]
- Statins are safe for rheumatoid arthritis patients: study on April 16, 2019 at 1:52 am
Patients with rheumatoid arthritis have an approximately 50 per cent higher risk of experiencing cardiovascular events such as heart attack and stroke compared with the general population.ANI ... […]
- Statins are safe for rheumatoid arthritis patients on April 16, 2019 at 1:05 am
A clinical study has indicated that statins are completely safe for rheumatoid arthritis patients and do not pose an additional risk. The research was published in the journal Arthritis & Rheumatology ... […]
- Statins Protect From Cardiovascular Events in Rheumatoid Arthritis on April 15, 2019 at 10:30 pm
Statins found to provide the same level of cardiovascular benefits to patients with rheumatoid arthritis as other individuals, without additional risks, according to a clinical trial. These findings ... […]
- Statins cleared for rheumatoid arthritis patients on April 15, 2019 at 9:11 pm
Statins are safe and effective for people with rheumatoid arthritis, a large clinical trial reveals. Patients with rheumatoid arthritis (RA) carry an increased risk of cardiovascular malfunction ... […]
- New Study Suggests Cannabis May Be Effective For Rheumatoid Arthritis, And Why It May Not Matter on April 15, 2019 at 1:51 pm
A recently published review, “Joints for Joints – cannabinoids in the treatment of rheumatoid arthritis,” cautiously concludes that “cannabinoids could be a suitable treatment for RA.” The authors ... […]
- Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins on April 15, 2019 at 1:08 pm
Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without ... […]
via Bing News